Overview of bisphosphonates
- 15 October 1997
- Vol. 80 (S8), 1652-1660
- https://doi.org/10.1002/(sici)1097-0142(19971015)80:8+<1652::aid-cncr15>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Long‐term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate‐containing liposomesArthritis & Rheumatism, 1995
- CELLULAR BIOLOGY OF BONE RESORPTIONBiological Reviews, 1993
- Metabolism of halogenated bisphosphonates by the cellular slime mould dictyostelium discoideumBiochemical and Biophysical Research Communications, 1992
- Disodium 1-hydroxy-3-(1-pyrrolidinyl)-propylidene-1,1-bisphosphonate (EB-1053) is a potent inhibitor of bone resorption in vitro and in vivoJournal of Bone and Mineral Research, 1992
- BisphosphonatesDrugs, 1991
- Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineageJournal of Bone and Mineral Research, 1990
- Isolation of EGF-dependent transforming growth factor (TGFβ-like) activity from culture medium conditioned by fetal rat calvariaeJournal of Bone and Mineral Research, 1987
- Diphosphonates inhibit bone resorption by macrophages in vitroThe Journal of Pathology, 1980
- Influence of dichloromethylene diphosphonate (Cl2MDP) and calcitonin on bone resorption, lactate production and phosphatase and pyrophosphatase content of mouse calvaria treated with parathyroid hormonein vitroCalcified Tissue International, 1973
- The effects of disodium ethane-1-hydroxy-1, 1-diphosphonate on adjuvant induced arthritis in ratsCalcified Tissue International, 1972